Willingness to participate in HIV vaccine trials: The impact of trial attributes
- 30 June 2007
- journal article
- research article
- Published by Elsevier BV in Preventive Medicine
- Vol. 44 (6), 554-557
- https://doi.org/10.1016/j.ypmed.2006.12.007
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- HIV vaccine acceptability among communities at risk: The impact of vaccine characteristicsVaccine, 2006
- HIV Vaccine Trial Participation Among Ethnic Minority CommunitiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Assessing the Attitudes, Knowledge, and Awareness of HIV Vaccine Research Among Adults in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Challenges for HIV Vaccine Dissemination and Clinical Trial Recruitment: If We Build It, Will They Come?AIDS Patient Care and STDs, 2004
- Barriers to participating in an HIV vaccine trialAIDS, 2004
- Determinants of Enrollment in a Preventive HIV Vaccine TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample.1999